Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin versus dexmedetomidine for sedative and analgesic effects
IRCT2016011822794N2Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of gabapentin and dexmedetomidine in anxiety disorder (2 arms), sponsored by Semnan University of Medical Sciences. Started Apr 2016; status: completed.
02
Drugs
gabapentindexmedetomidine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on IRCT2016011822794N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016011822794N2.